Other Clinical Trial - Neoadjuvant Chemoimmunotherapy in Stage IIIA-

Updated 06/21/2024

Status Not yet recruiting

Clinical Trial Summary

to explore the impact of preoperative neoadjuvant immunotherapy on perioperative outcomes and long-term prognosis of locally advanced NSCLC in the real world

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Non-small Cell Lung Cancer Stage ?A
Non-small Cell Lung Cancer Stage IIIB

Clinical Trial Details

NCT number	NCT06394427
Study type	Observational
Source	West China Hospital
Contact
Status	Not yet recruiting
Phase
Start date	May 2024
Completion date	August 2025

See also
	Status	Clinical Trial	Phase
	Active, not recruiting	`NCT02035683` - PET/CT Scan as a Tool to Rationalize the Treatment of of Advanced NSCLC Patients Undergoing First Chemotherapy	N/A
	Terminated	`NCT00766246` - Phase II Avastin Trial for Stage IIIB/IV NSCLC	Phase 2
	Terminated	`NCT03386929` - Survival Prolongation by Rationale Innovative Genomics	Phase 1/Phase 2
	Recruiting	`NCT01493011` - Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer	N/A
	Terminated	`NCT01348126` - Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer	Phase 2/Phase 3
	Recruiting	`NCT05919264` - FOG-001 in Locally Advanced or Metastatic Solid Tumors	Phase 1/Phase 2
	Recruiting	`NCT05713006` - Alectinib Pharmacokinetic in Patients With NSCLC	Phase 1/Phase 2
	Terminated	`NCT01798485` - A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC	Phase 3
	Active, not recruiting	`NCT01405586` - MILES-3: Cisplatin in Combination With Gemcitabine for Elderly Patients With Lung Cancer	Phase 3
	Withdrawn	`NCT03628144` - Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer	Phase 2
	Completed	`NCT02176369` - Maintenance Low Dose Oral Navelbine In Patients With Non Small Cell Lung Cancer - MA.NI.LA Trial	Phase 2
	Active, not recruiting	`NCT03611738` - Ceritinib Plus Docetaxel in ALK-Negative, EGFR WT Advanced NSCLC	Phase 1
	Completed	`NCT01473563` - A Study of Home Administration of Pemetrexed as Maintenance Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC)	Phase 2
	Active, not recruiting	`NCT01656551` - MILES-4: Study Comparing Gemcitabine and Pemetrexed, With or Without Cisplatin, in Patients With Nonsquamous Lung Cancer	Phase 3
	Not yet recruiting	`NCT03543683` - Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC
	Not yet recruiting	`NCT03532698` - Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC)